次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

プレフィルドシリンジ(薬液充填済注射器)の世界市場2015-2025年

PRE-FILLED SYRINGES MARKET FORECAST 2015-2025
Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes

出版元:Visiongain(英国)出版元情報LinkIcon
発行年:2015年2月
定価 Single User License(1名様ライセンス) 1,799 GBP(英国ポンド) / Department License(5名様ライセンス) 2,999GBP/ Site License 4,999GBP / Global Site License 6,999GBP
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email (※デジタル著作権管理/DRM設定有り)
当調査レポートは英文250ページになります。
商品コード:VGN370

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



※当レポートは、更新版(2016-2026年版)が発行されております。更新版は下記リンクよりご参照ください。

LinkIconプレフィルドシリンジ(薬液充填済注射器)の世界市場2016-2026年

【レポート紹介】
プレフィルドシリンジ(薬液充填済み注射器)の世界市場規模は2015年に43億ドルに達すると推計され、2025年にかけて堅調な市場拡大が見込まれます。慢性疾患治療への需要増加、生物製剤とバイオシミラーの市場参入、および革新的な注射デバイスなどは、市場の促進要因となるでしょう。先進国、新興国ともに成長基調ですが、特にインド、中国、ブラジル、メキシコで高成長が期待されます。世界規模での注射剤の新薬投入や、デバイスの技術革新などは市場の追い風となるでしょう。当レポートでは、プレフィルドシリンジの世界市場予測(2015-2025)、詳細セグメント別市場予測、主要製品別売上予測、主要国別市場予測、リーディング企業動向、専門家オピニオンインタビューなどを織り交ぜ、概略以下の構成でお届けいたします。

【レポート構成概要】VGN370_thumbnail_Prefilled_Syringes2025.jpg
・プレフィルドシリンジの世界市場予測2015-2025
・全250ページ、168個のデータ表とグラフ類

・セグメント別市場予測2015-25
- ガラス製プレフィルドシリンジ
- プラスチック製プレフィルドシリンジ
- ペン型および自己注射

・主要薬剤市場予測
- インスリン治療
- 関節リウマチ治療
- 多発性硬化症の治療
- 成長ホルモン
- ヘパリン
- ワクチン
- PCSK9阻害剤

・主要11製品別、売上予測2015-25
- Lantus
- NovoRapid/NovoLog
- Humalog
- Humira
- Enbrel
- Avonex
- Rebif
- Copaxone
- Norditropin
- Genotropin
- Lovenox.

・主要12ヶ国、国・地域別市場予測2015-25
- 米国
- 日本
- 中国
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- インド
- ブラジル
- メキシコ
- EU5(英仏独西伊、合算)
- BRIC諸国(ブラジル、ロシア、インド、中国合算)
- その他地域(RoW)

・リーディング企業7社プロフィール、プレフィルドシリンジ業績2009-14、新製品、提携、M&A、展望
- BD
- Gerresheimer
- Schott
- SHL Group
- Ypsomed
- Datwyler
- West Pharmaceutical Services.


・市場動向(諸論点)
- 慢性疾患の有病率増加によるプレフィルドシリンジへの需要増加
- 生物製剤、バイオシミラー、注射剤の強力な開発パイプライン
- 特許期限切れとジェネリックとの競合
- 人間工学設計と注射針安全などの規制面
- 価格設定と費用償還

・業界専門家オピニオンインタビュー:
- Gerresheimer AG
- Richard Harrison, Business Development Manager, Injectables, Bespak Europe
- An interview with an anonymous expert from a leading pre-filled syringes manufacturer

・調査結論

visiongain is a trading partner with the US Federal Government
【レポート詳細目次、データ項目一覧(List of Tables)は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

PRE-FILLED SYRINGES MARKET FORECAST 2015-2025
Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes

Table of Contents

1. Report Overview

1.1 Global Pre-Filled Syringes Market Overview
1.2 Global Pre-Filled Syringes Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pre-Filled Syringes

2.1 What are Pre-Filled Syringes?
2.1.1 A Brief History of Pre-Filled Syringes
2.2 Design and Manufacture of Pre-Filled Syringes
2.2.1 Glass and Plastic Syringes
2.2.2 Safety and the Pre-Filled Syringe Market
2.2.3 Concerns over Needlestick Injuries
2.3 An Introduction to Pen Injectors and Autoinjectors
2.3.1 Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.3.2 What Determines Injection Device Choice?
2.4 Glass versus Plastic
2.4.1 Glass
2.4.2 Plastic
2.5 Future Directions for Pre-Filled Syringes
2.6 Pre-Filled Syringes: Market Segmentation
2.7 Scope of this Report
2.7.1 Products Excluded from this Report
2.8 Currency Exchange Rates in This Report

3. Pre-Filled Syringes: World Market 2015-2025

3.1 Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2 The World Pre-Filled Syringes Market in 2013 and 2014
3.2.1 World Pre-Filled Syringes Market: Market Shares by Segment 2013
3.2.2 Leading Companies in the Pre-Filled Syringes Market
3.3 World Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.4 World Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.5 How Will Segmental Market Shares Change to 2025?
3.6 World Pre-Filled Syringes Market: Drivers and Restraints 2015-2025
3.6.1 Biologics and Biosimilars to Drive Market Growth
3.6.2 Human Factors and Regulatory Requirements
3.6.3 Advances in Pre-Filled Syringe Manufacturing
3.6.4 Market Genericisation and Pre-Filled Syringes
3.6.5 The Injectable Drug Pipeline is Substantial
3.6.6 Competing Drug Delivery Technologies
3.7 Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.7.1 Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.7.2 Glass Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.7.3 Glass Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.8 Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.8.1 Plastic Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.8.2 Plastic Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.8.3 Plastic Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.9 Pen Injectors and Autoinjectors: A Growing Segment
3.9.1 Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2015-2025
3.9.2 Pen Injectors and Autoinjectors Market: Sales Forecast by Volume, 2015-2025
3.9.3 Pen Injectors and Autoinjectors: Drivers and Restraints 2015-2025
3.9.4 Insulin and Other Biologics to Lead Market Growth

4. Leading National and Regional Markets 2015-2025

4.1 National Breakdown of the World Pre-Filled Syringes Market
4.2 World Pre-Filled Syringes Market: National Markets Forecast 2015-2025
4.2.1 How Will National Market Shares Change to 2025?
4.3 Regional Breakdown of the World Pre-Filled Syringes Market
4.4 World Pre-Filled Syringes Market: Regional Markets Forecast 2015-2025
4.4.1 How Will Regional Market Shares Change to 2025?
4.5 US Pre-Filled Syringes Market Forecast 2015-2025
4.5.1 US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1 New Drug and Device Launches to Drive Growth to 2025
4.5.1.2 The Budget Control Act 2011 and the Medical Excise Tax
4.6 Japanese Pre-Filled Syringes Market Forecast 2015-2025
4.7 EU5 Pre-Filled Syringes Market Forecast 2015-2025
4.8 Emerging Markets: Pre-Filled Syringes Market Forecast 2015-2025
4.8.1 Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2 Chinese Pre-Filled Syringes Market Forecast 2015-2025
4.8.2.1 China’s Five Year Plans Prioritise Biotechnology
4.8.3 Indian Pre-Filled Syringes Market Forecast 2015-2025
4.8.4 Russian Pre-Filled Syringes Market Forecast 2015-2025
4.8.5 Brazilian Pre-Filled Syringes Market Forecast 2015-2025
4.8.6 Mexican Pre-Filled Syringes Market Forecast 2015-2025

5. Leading Therapeutic Sectors for Pre-Filled Syringes 2015-2025

5.1 Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2014
5.1.1 Vaccines and Heparins Are Major Market Sectors
5.1.2 Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3 Growth for Key Market Sectors 2015-2025
5.2 Pre-Filled Syringes and Pen Injectors for Diabetes 2015-2025
5.2.1 Insulin Market Forecast 2015-2025
5.2.2 High Rates of Pen Injector Use in the EU and Japan
5.2.3 Insulin Pumps: A Technology to Challenge Pen Injectors to 2025?
5.2.4 MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5 Biosimilar Insulin to Reach the Market in 2015?
5.2.5.1 Injection Devices for Biosimilar Insulin Products
5.3 Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1 Rheumatoid Arthritis Market Forecast 2015-2025
5.3.2 All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3 Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4 The Receding Threat from Oral Therapies to 2025
5.4 Self-Injection for Multiple Sclerosis: Outlook 2015-2025
5.4.1 Multiple Sclerosis Market Forecast 2015-2025
5.4.2 All Interferon Betas Available in Autoinjectors from 2014
5.4.3 Oral Therapies to Drive MS Market Growth in this Decade
5.5 Growth Hormones: Outlook to 2025
5.5.1 Growth Hormones Market Forecast 2015-2025
5.5.2 Biosimilar Growth Hormones and Pen Injectors
5.5.3 Uptake of Needle-Free Injectors for Growth Hormones
5.6 Pre-Filled Heparin Syringes 2015-2025
5.6.1 One Brand Led the Heparin Market in 2014
5.6.2 Pre-Filled Syringes for LMWHs
5.6.3 Heparin Market Forecast 2015-2025
5.6.4 Follow-On Heparins: Biosimilars or Generics?
5.7 The Vaccine Market Outlook 2015-2025
5.7.1 Vaccine Market Forecast 2015-2025
5.7.2 Single-Use Devices for Vaccine Delivery
5.7.2.1 BD Uniject: A Private-Public Collaboration
5.7.3 Needle-Free Injectors for Vaccines
5.7.4 Other Trends in Vaccine Delivery
5.8 PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.8.1 PCSK9 Inhibitors Market Forecast 2015-2025
5.8.2 PCSK9 Inhibitors and Pre-Filled Syringes/Injectors

6. Leading Pre-Filled Device Therapies 2015-2025

6.1 Leading Insulin Therapies Using Pen Injectors 2015-2025
6.1.1 Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1 SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2 Lantus: Sales Forecast 2015-2025
6.1.2 NovoLog: The Leading Fast-Acting Insulin
6.1.2.1 NovoLog FlexPen: To Be Retired
6.1.2.2 Novo’s New FlexTouch Pen Launched
6.1.2.3 NovoLog: Sales Forecast 2015-2025
6.1.3 Humalog
6.1.3.1 Humalog: HumaPen and KwikPen
6.1.3.2 Humalog: Sales Forecast 2015-2025
6.2 Top Biologics for Rheumatoid Arthritis: Device Outlook to 2025
6.2.1 Humira: The Biggest-Selling Drug in 2013
6.2.1.1 The Humira Pen Is an Innovative Delivery Device
6.2.1.2 Humira: Sales Forecast 2015-2025
6.2.2 Enbrel: The Leading Competitor to Humira
6.2.2.1 Pre-Filled Injection Devices Available for Enbrel in 2014
6.2.2.2 Enbrel: Sales Forecast 2015-2025
6.3 Multiple Sclerosis: Leading Injectable Therapies 2015-2025
6.3.1. Copaxone: An Injectable Non-Interferon Therapy
6.3.1.1 Copaxone Uses Owen Mumford’s Autoject 2 Autoinjector
6.3.1.2 Next-Generation Copaxone and Generics Expected in 2015
6.3.1.3 Copaxone: Sales Forecast 2015-2025
6.3.2 Avonex
6.3.2.1 Biogen Idec Launched the Avonex Pen in 2011
6.3.2.2 Avonex: Sales Forecast 2015-2025
6.3.3 Rebif
6.3.3.1 Rebif Self-Injection Options: Rebiject II, RebiSmart and RebiDose
6.3.3.2 Rebif: A Similar Outlook to Avonex to 2025?
6.4 Growth Hormones: Two Products Dominated the Market in 2014
6.4.1 Norditropin: the Leading Growth Hormone
6.4.1.1 Norditropin: Sales Forecast 2015-2025
6.4.2 Genotropin: Sales Forecast 2015-2025
6.5 Outlook for Leading Heparin Products 2015-2025
6.5.1 Lovenox: Generic Competition in the US Since 2010
6.5.1.1 Lovenox: Sales Forecast 2015-2025
6.5.2 Fragmin Faces Rivalry from Generic Competition to Lovenox
6.5.2.1 Fragmin: Sales Forecast 2015-2025
6.5.3 Arixtra: Aspen and Mylan Hold Marketing Rights
6.5.3.1 Arixtra: Sales Forecast 2015-2025

7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2015

7.1 Leading Pre-Filled Syringe Manufacturers in 2014
7.1.1 BD: The Market Leader
7.1.1.1 BD: Pre-Filled Syringes Product Portfolio
7.1.1.2 BD: Market Outlook 2015-2025
7.1.1.3 Recent Acquisitions by BD
7.1.1.4 BD Merging with CareFusion
7.1.1.5 BD AutoShield Duo Pen Needle Launched in 2014
7.1.2 Gerresheimer
7.1.2.1 Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2 Gerresheimer: Market Outlook 2015-2025
7.1.2.3 Gerresheimer: Products in Development
7.1.2.4 Patent Application for Gerresheimer’s Gx G-Fix Adapter
7.1.2.5 Gerresheimer Commissioned to Manufacture Simponi Autoinjectors?
7.1.2.6 Gerresheimer Opens First Development Center in China
7.1.3 Schott
7.1.3.1 Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2 Schott: Market Outlook 2015-2025
7.1.3.3 Schott: Expansion in India
7.2 Other Notable Pre-Filled Syringe Manufacturers
7.2.1 Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2 Nipro: Leading Japanese Contract Manufacturer
7.2.2.1 Nipro’s 2012 Acquisition of MGlas
7.2.3 Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.3.1 Ompi’s Ambitious Geographical Expansion Planned to 2016
7.2.4 Weigao: Pre-Filled Syringes for China and Beyond
7.2.5 Unilife: Pre-Filled Safety Syringes
7.2.6 Roselabs: Entered the Market in 2012
7.2.7 Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8 Other Companies
7.3 Leading Pen Injector and Autoinjector Manufacturers in 2014
7.3.1 SHL Group
7.3.1.1 SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2 SHL Group: Market Outlook 2015-2025
7.3.2 Ypsomed
7.3.2.1 Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2 Ypsomed: Market Outlook 2015-2025
7.3.2.3 Ypsomed: Recent Developments
7.3.3 Haselmeier
7.3.3.1 Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2 Haselmeier: Market Outlook 2015-2025
7.3.4 Owen Mumford
7.3.4.1 Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.4.2 Owen Mumford: Market Outlook 2015-2025
7.3.5 Bespak: Entering the Auto-Injectors Market
7.3.6 Other Leading and Emerging Autoinjector Manufacturers
7.4 Leading Pre-Filled Syringe Component Manufacturers in 2014
7.4.1 Datwyler
7.4.1.1 Datwyler: Market Outlook 2015-2025
7.4.2 West Pharmaceutical Services
7.4.2.1 West Pharmaceutical Services: Market Outlook 2015-2025

8. Qualitative Analysis of the Pre-Filled Syringes Market 2015-2025

8.1 SWOT Analysis of the Pre-Filled Syringes Market
8.2 Strengths
8.2.1 Pre-Filled Syringes and Pen/Autoinjectors Are Used In Chronic Conditions
8.2.2 Device Manufacturers Offer a Range Of Products
8.2.3 Customisation and Product Differentiation
8.2.4 Effective Lifecycle Management
8.3 Weaknesses
8.3.1 Patients with Needle Phobia
8.3.2 Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3 Risk of Extractables and Leachables
8.3.4 Higher Cost and Greater Cold Chain and Storage Requirements
8.4 Opportunities
8.4.1 Biosimilars Represent a Growing Market
8.4.2 Viscous and Large-Volume Drugs Require Novel Devices
8.4.3 Technological Developments Expanding Product Portfolios
8.4.4 Many Injectable Drugs in the Pipeline
8.4.5 Growth in Emerging Markets
8.5 Threats
8.5.1 Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2 New Oral Therapies for Many Chronic Conditions
8.5.3 Increasing Regulatory Barriers
8.5.4 Cost Pressures on Healthcare Payers
8.6 STEP Analysis of the Pre-Filled Syringes Market
8.6.1 Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2 Technological Developments: Improved Safety and Administration
8.6.3 Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1 High Barriers to Market Entry Exist
8.6.4 Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7 Regulatory and Safety Outlook for Pre-Filled Syringes, 2015-2025
8.7.1 Needlestick Safety and Prevention
8.7.2 International Regulations for Needlestick Prevention
8.7.2.1 The US: The First Country to Introduce Needlestick Legislation
8.7.2.2 The EU: New Rules from 2013 Onwards
8.7.2.3 Needlestick Safety in Japan 2015-2025
8.7.2.4 Legislation for Needlestick Safety in Emerging Markets
8.7.3 Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1 Ancillary versus Integrated Safety Devices
8.7.4 Extractables and Leachables
8.7.4.1 Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2 Products that Minimise Extractables and Leachables
8.7.4.3 Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4 Regulatory Requirements for Extractables and Leachables, 2015
8.8 Biologics and the Pre-Filled Syringes Market, 2015-2025
8.8.1 Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2 Biologics Provide New Challenges for Device Manufacturers
8.8.2.1 Lyophilised Drugs and Dual-Chamber Devices
8.8.3 Delivery Opportunities for High Viscosity Drugs
8.8.4 Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9 The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1 Chronic Disease Incidence 2015-2025
8.9.2 The Rise in At-Home Care
8.9.3 Improving Patient Adherence
8.9.4 Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10 Technological Developments in Pre-Filled Syringes to 2025
8.10.1 Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2 Product Customisation: Adapting Injection Devices
8.10.3 Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4 Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1 Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2 Patients Prefer Oral Drug Delivery
8.11 Outsourcing in the Pre-Filled Syringe Industry
8.11.1 Contract Medical Device Manufacturing
8.11.2 Contract Filling of Pre-Filled Syringes

9. Research Interviews

9.1 Interview with an Anonymous Expert from a Leading Pre-Filled Syringes Manufacturer
9.1.1 Products and Services Provided
9.1.2 Opportunities in Pre-Filled Syringes
9.1.3 Prominent Therapeutic Areas in 2015-2025
9.1.4 Trends and Developments in Pre-Filled Syringes
9.1.5 Challenges and Future Outlook
9.2 Interview with Gerresheimer AG, Düsseldorf, Germany
9.2.1 Gerresheimer’s Products and Services
9.2.2 Gerresheimer’s Development Center in China for Device Contract Manufacturing
9.2.3 Trends and Developments in Pre-Filled Syringes and Injectors
9.2.4 Will Consulting Become More Important?
9.2.5 Challenges for Manufacturers
9.2.6 The Outlook for Pre-Filled Syringes and Pen/Autoinjectors through 2015-2025
9.3 Interview with Richard Harrison, Business Development Manager, Injectables, Bespak Europe
9.3.1 Bespak
9.3.2 Unmet Needs and Future Directions for Autoinjectors
9.3.3 Challenges in Developing Autoinjectors
9.3.4 Trends from Drug Development Impacting Device Manufacturers

10. Conclusions

10.1 Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
10.2 The World Pre-Filled Syringes Market in 2014
10.2.1 Current Leading Pre-Filled Syringes Segments
10.2.2 Leading Pre-Filled Syringes Companies
10.2.3 Leading National and Regional Markets
10.3 World Pre-Filled Syringes Market Forecast 2015-2025
10.4 The Future of the Pre-Filled Syringes Market?
10.4.1 Glass Syringes Will Continue to Dominate
10.4.2 Innovation for Growth

11. Glossary

List of Tables

Table 1.1 Leading National Pre-Filled Syringes Market Forecast 2015 ($m, AGR%)
Table 2.1 Currency Exchange Rates, 2013 and 2014
Table 3.1 World Pre-Filled Syringes Market: Revenue ($m) and Units (m), 2013-2014
Table 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Segment, 2014-2025
Table 3.3 World Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%) by Segment, 2014-2025
Table 3.4 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2014, 2019 and 2025
Table 3.5 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Volume, 2014, 2019 and 2025
Table 3.6 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.7 Glass Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 3.8 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2015
Table 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.10 Plastic Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 3.12 Pen Injectors and Autoinjectors Market Forecast: Volume (m units), AGR (%), CAGR (%), 2014-2025
Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2014
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by National Market, 2014-2025
Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2014, 2019 and 2025
Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2014
Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Regional Market, 2014-2025
Table 4.6 Market Shares (%) of Leading Regional Pre-Filled Syringes Markets, 2014, 2019 and 2025
Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.8 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.9 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%) by National Market, 2014-2025
Table 4.10 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.11 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.12 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.13 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 4.14 Mexican Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2014
Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2015
Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.4 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.5 Interferon Beta Therapies for Multiple Sclerosis, 2015
Table 5.6 Oral Therapies Launched for Multiple Sclerosis, 2010-2014
Table 5.7 Multiple Sclerosis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.8 Growth Hormone Therapies in Pen Injectors, 2015
Table 5.9 Growth Hormones Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.10 Selected Biosimilar Growth Hormones in Emerging Markets, 2014
Table 5.11 Heparins Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.12 Vaccines Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 5.13 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.5 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.6 AbbVie/Eisai: Humira Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.7 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.8 Leading Pre-Filled Multiple Sclerosis Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.9 Teva: Copaxone Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.10 Biogen Idec: Avonex Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.11 Merck Serono: Rebif Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.12 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.13 Novo Nordisk: Norditropin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.14 Pfizer: Genotropin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.15 Leading Pre-Filled Heparins: Revenues ($m), AGR (%), CAGR (%), 2009-2013
Table 6.16 Sanofi: Lovenox Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.17 Pfizer/Eisai: Fragmin Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.18 Aspen/Mylan: Arixtra Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 7.1 BD: Overview, 2015
Table 7.2 BD: Pre-Filled Injection Systems, 2015
Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.4 Gerresheimer: Overview, 2015
Table 7.5 Gerresheimer: Plastic Systems and Tubular Glass Revenue ($m), AGR (%), CAGR (%), 2009-2013
Table 7.6 Schott: Overview, 2015
Table 7.7 Schott: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.8 Weigao: Pre-Filled Syringes Revenue ($m) and Production Volume (m units), AGR (%), CAGR (%), 2009-2014
Table 7.9 Unilife: Pre-Filled Syringe Product Portfolio, 2015
Table 7.10 Unilife: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.11 SHL Group: Overview, 2015
Table 7.12 SHL Group: Pen Injector and Autoinjector Portfolio, 2015
Table 7.13 Ypsomed: Overview, 2015
Table 7.14 Ypsomed: Pen Injector and Autoinjector Portfolio, 2015
Table 7.15 Ypsomed: Delivery Devices Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.16 Haselmeier: Overview, 2015
Table 7.17 Haselmeier: Pen Injector and Autoinjector Portfolio, 2015
Table 7.18 Owen Mumford: Overview, 2015
Table 7.19 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2015
Table 7.20 Owen Mumford: Net Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.21 Datwyler: Overview, 2015
Table 7.22 Datwyler: Pharma Packaging Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.23 West Pharmaceutical Services: Overview, 2015
Table 7.24 West Pharmaceutical Services: Packaging Systems and Delivery Systems Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2015
Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2015-2025
Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2015
Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2015
Table 8.5 Leading Blockbuster Biologic Patent Expiries in the US and EU, 2013-2028
Table 8.6 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2016
Table 8.7 Selected Insulin Pumps Available, 2015
Table 8.8 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2015-2025
Table 8.9 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2015
Table 9.1 Bespak: Needle-Free Injectors, 2014

List of Figures

Figure 1.1 World 65+ Population Forecast: Size (m), AGR (%), 2014-2025
Figure 1.2 Global Pre-Filled Syringes Market Segmentation Overview, 2015
Figure 2.1 Diagram of Syringe Parts, 2015
Figure 2.2 Timeline of Pre-Filled Syringe Development, 1950-2014
Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2015
Figure 3.1 World Pre-Filled Syringes Market: Revenue ($m) and Units (m), 2013-2014
Figure 3.2 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2013
Figure 3.3 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2013
Figure 3.4 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.5 World Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.6 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2014
Figure 3.7 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2019
Figure 3.8 World Pre-Filled Syringes Market by Value: Market Shares (%) by Segment, 2025
Figure 3.9 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2014
Figure 3.10 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2019
Figure 3.11 World Pre-Filled Syringes Market by Volume: Market Shares (%) by Segment, 2025
Figure 3.12 World Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.13 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.14 Glass Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.15 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.16 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.17 Plastic Pre-Filled Syringes Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.18 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2015-2025
Figure 3.19 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 3.20 Pen Injectors and Autoinjectors Market Forecast: Volume (m units), AGR (%), 2014-2025
Figure 3.21 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2015-2025
Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2014
Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2014
Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2019
Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2025
Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2014
Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2014
Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2019
Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2025
Figure 4.9 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.11 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2014-2025
Figure 4.12 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.13 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.14 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.15 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 4.16 Mexican Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.1 Insulin Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.2 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.3 Multiple Sclerosis Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.4 Growth Hormones Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.5 Heparins Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.6 Vaccines Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 5.7 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.1 Sanofi: Lantus Revenue ($m), AGR (%), 2014-2025
Figure 6.2 Novo Nordisk: NovoLog Revenue ($m), AGR (%), 2014-2025
Figure 6.3 Eli Lilly: Humalog Revenue ($m), AGR (%), 2014-2025
Figure 6.4 AbbVie/Eisai: Humira Revenue ($m), AGR (%), 2014-2025
Figure 6.5 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%), 2014-2025
Figure 6.6 Teva: Copaxone Revenue ($m), AGR (%), 2014-2025
Figure 6.7 Biogen Idec: Avonex Revenue ($m), AGR (%), 2014-2025
Figure 6.8 Merck Serono: Rebif Revenue ($m), AGR (%), 2014-2025
Figure 6.9 Novo Nordisk: Norditropin Revenue ($m), AGR (%), 2014-2025
Figure 6.10 Pfizer: Genotropin Revenue ($m), AGR (%), 2014-2025
Figure 6.11 Sanofi: Lovenox Revenue ($m), AGR (%), 2014-2025
Figure 6.12 Pfizer/Eisai: Fragmin Revenue ($m), AGR (%), 2014-2025
Figure 6.13 Aspen/Mylan: Arixtra Revenue ($m), AGR (%), 2014-2025
Figure 7.1 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2009-2014
Figure 7.2 Gerresheimer: Plastic Systems and Tubular Glass Revenue ($m), AGR (%), 2009-2013
Figure 7.3 Schott: Net Revenue ($m), AGR (%), 2009-2013
Figure 7.4 Weigao: Pre-Filled Syringes Revenue ($m) and Production Volume (m units), 2009-2014
Figure 7.5 Unilife: Net Revenue ($m), AGR (%), 2009-2014
Figure 7.6 Ypsomed: Delivery Devices Revenue ($m), AGR (%), 2009-2014
Figure 7.7 Owen Mumford: Net Revenue ($m), AGR (%), 2009-2014
Figure 7.8 Datwyler: Pharma Packaging Revenue ($m), AGR (%), 2009-2014
Figure 7.9 West Pharmaceutical Services: Packaging Systems and Delivery Systems Revenue ($m), AGR (%), 2009-2014
Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2015-2025
Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2015-2025
Figure 10.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2014-2025
Figure 10.2 World Pre-Filled Syringes Market Forecast: Volume (m units) by Segment, 2014-2025

掲載企業リスト

Companies Listed

AbbVie
Aché Laboratórios Farmacêuticos
Aesica Pharmaceuticals
AI Biosciences
Alchemia
Althea Technologies
Alverix, Inc. (acquired by BD)
Amega Biotech
Amgen
AMRI
Animas Corporation (acquired by Johnson & Johnson)
Antares Pharma
Aptar Pharma
Aptar Stelmi (part of Aptar Pharma)
Asante Solutions
Aspen Pharmacare Holdings
AstraZeneca
Baxter International
Bayer AG
Becton, Dickinson & Company (BD)
Berlin-Chemie
Bespak (subsidiary of Consort Medical)
Biocon
BioConnection
Biodel Inc.
Biogen Idec
Bioject Medical Technologies
Biopartners GmbH
Biosidus
Boehringer Ingelheim
Bristol-Myers Squibb (BMS)
Cambridge Consultants
CareFusion Corporation (acquired by BD)
Carl Zeiss Foundation
Catalent
Cato Software Solutions (acquired by BD)
Celgene Corporation
Cellnovo
Centocor (subsidiary of Johnson & Johnson)
Cipla
Consort Medical
Credence MedSystems
Crossject
D. Medical Industries
Daiichi Sankyo
Daikyo Seiko
Datwyler
Disetronic Group (acquired by Roche)
Dong-A Pharmaceutical Co. Ltd.
Dr. Reddy's Laboratories
Duoject
Eisai
Elcam Medical
Eli Lilly & Company (Lilly)
Express Scripts
Ferring Pharmaceuticals
Future Injection Technologies
Gan & Lee Pharmaceutical
GenCell Biosystems (acquired by BD)
Genentech (subsidiary of Roche)
GeneScience Pharmaceuticals
Gerresheimer
GSK
Hankook Sealtech (acquired by Datwyler)
Haselmeier
Helvoet Pharma (part of Datwyler)
Hikma Pharmaceuticals
Hospira (recently acquired by Pfizer)
Hyaluron Contract Manufacturing (acquired by AMRI)
Incyte Pharmaceuticals
Innoscan (subsidiary of the Stevanato Group)
Insulet Corporation
Jabil Circuit
Janssen Biotech (part of Johnson & Johnson)
Jefferies Group
Johnson & Johnson (J&J)
Keystone Holdings / Columbia Engineered Rubber (acquired by Datwyler)
KIESTRA Lab Automation BV (acquired by BD)
LG Life Sciences
MannKind Corporation
MedImmune (part of AstraZeneca)
Medimop Medical Projects (part of West Pharmaceutical Services)
Medtronic
Merck & Co, (Merck)
Merck Serono (Merck KGaA)
MG Sterile Products (acquired by Nipro)
MGlas (acquired by Nipro)
Mitsubishi Tanabe
Momenta Pharmaceuticals
Mylan
Natco Pharma
Nedis (part of Datwyler)
Nektar Therapeutics
Nemera (formerly Rexam)
Neutral Glass & Allied Industries (acquired by Gerresheimer)
Nipro Corporation
Nipro Medical Corporation (subsidiary of Nipro)
Novartis
Novo Nordisk
Nypro (part of Jabil Circuit)
Ompi (part of the Stevanato Group)
OPKO Health
Optrel (subsidiary of the Stevanato Group)
Oval Medical
Owen Mumford
PA Consulting Group
Palatin Technologies
Pfizer
PharmaJet
Pharmstandard
Phillips-Medsize
Plastef Investissements
Polfa-Tarchomin
Primequal
Regeneron
Revolutions Medical
Rhône Poulenc-Rorer (later subsidiary of Sanofi)
Rigel Pharmaceuticals
Roche
Roehr Products (later acquired by Brunswick Corporation)
Roselabs Bioscience (part of Roselabs Group)
Roselabs Group
ROVI
Safety Syringes (acquired by BD)
Samsung Biologics
Sandoz (division of Novartis)
Sanofi
Schering-Plough (part of Merck)
Schott AG
Schott Kaisha (Schott joint venture)
Schott Xinkang Pharmaceutical Packaging (Schott joint venture)
SciGen Ltd.
Shandong Weigao Group Medical Polymer Company (Weigao)
Shanghai Celgen Bio-Pharmaceutical
Shanghai CP Guojian
SHL Group (Scandinavian Health Ltd)
Sirigen Group Limited (acquired by BD)
SOOIL
Spami (subsidiary of the Stevanato Group)
Specialty Coating Systems
Synthon
Taisei Kako
Takeda Pharmaceutical Company
Tandem Diabetes Care
Terumo Corporation
Teva
The Medical House (acquired by Consort Medical)
The Stevanato Group
tip-top
Tonghua Dongbao
Triveni Polymers (acquired by Gerresheimer)
UCB
Unilife
Valeritas
Vedat Tampas Herméticas (now Gerresheimer Plásticos São Paulo)
Vetter Pharma
Weigao Group Pharmaceutical Packaging Products Company (subsidiary of Weigao)
West Pharmaceutical India Packaging Private (subsidiary of West Pharmaceutical Services)
West Pharmaceutical Services
Wilden Group (now Gerresheimer Regensburg)
Wockhardt
Wyeth (part of Pfizer)
Ypsomed
Zeon Corporation
Zhongding Sealtech (acquired by Datwyler)

Other Organisations Mentioned in this Report

Battelle Memorial Institute
China Food and Drug Administration (CFDA)
COFEPRIS (Mexico)
European Medicines Agency (EMA)
GAVI Alliance (formerly Global Alliance for Vaccines and Immunizations)
Johns Hopkins University
Massachusetts Institute of Technology (MIT)
Ministry of Health, Labour and Welfare (MHLW) (Japan)
Ministry of Labour and Employment (Brazil)
Pan American Health Organization (PAHO)
Parenteral Drug Association
PATH (Program for Appropriate Technology in Health)
UK National Health Service (NHS)
UNICEF (United Nations Children's Fund)
United States Food and Drug Administration (FDA)
University of Virginia
US Agency for International Development
US Centers for Disease Control and Prevention (CDC)
US Securities and Exchange Commission (SEC)
World Health Organization (WHO)

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

2319881.jpg国内外のスマートグリッド関連ニュース、リサーチ情報等を収集し隔週でお届けいたします。日本そして海外の企業動向、新製品、政府支援、技術開発、規格、導入事例、投資、調査発表など幅広く情報を定期配信いたします。
スマートグリッド・ニュースへLinkIcon


ニュースページへLinkIcon

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。